These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16923573)

  • 1. Detection of N-RAS and K-RAS in their active GTP-bound form in acute myeloid leukemia without activating RAS mutations.
    Ehmann F; Horn S; Garcia-Palma L; Wegner W; Fiedler W; Giehl K; Mayr GW; Jücker M
    Leuk Lymphoma; 2006 Jul; 47(7):1387-91. PubMed ID: 16923573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational and indirect activation.
    Raepple D; von Lintig F; Zemojtel T; Duchniewicz M; Jung A; Lübbert M; Boss GR; Scheele JS
    Ann Hematol; 2009 Apr; 88(4):319-24. PubMed ID: 18784923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia.
    Reuter CW; Krauter J; Onono FO; Bunke T; Damm F; Thol F; Wagner K; Göhring G; Schlegelberger B; Heuser M; Ganser A; Morgan MA
    Ann Hematol; 2014 Jun; 93(6):977-82. PubMed ID: 24737308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples.
    Shih LY; Liang DC; Huang CF; Chang YT; Lai CL; Lin TH; Yang CP; Hung IJ; Liu HC; Jaing TH; Wang LY; Yeh TC
    Leukemia; 2008 Feb; 22(2):303-7. PubMed ID: 17960171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia.
    Nakagawa T; Saitoh S; Imoto S; Itoh M; Tsutsumi M; Hikiji K; Nakamura H; Matozaki S; Ogawa R; Nakao Y
    Oncology; 1992; 49(2):114-22. PubMed ID: 1574246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ras oncogene activation and occupational exposures in acute myeloid leukemia.
    Taylor JA; Sandler DP; Bloomfield CD; Shore DL; Ball ED; Neubauer A; McIntyre OR; Liu E
    J Natl Cancer Inst; 1992 Nov; 84(21):1626-32. PubMed ID: 1433344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic K-ras in mouse models of myeloproliferative disease and acute myeloid leukemia.
    Chan IT; Gilliland DG
    Cell Cycle; 2004 May; 3(5):536-7. PubMed ID: 15020845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low frequency of ras oncogene mutations in Philadelphia-positive acute leukemia and report of a novel mutation H61 Leu in a single case.
    Urbano-Ispizua A; Gill R; Matutes E; Levi S; Wiedemann LM; Catovsky D; Marshall CJ
    Leukemia; 1992 Apr; 6(4):342-6. PubMed ID: 1588796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implication of N-RAS gene mutations in Egyptian adult acute myeloid leukemia.
    Elghannam DM; Abousamra NK; Shahin DA; Goda EF; Azzam H; Azmy E; El-Din MS; El-Refaei MF
    Egypt J Immunol; 2009; 16(1):9-15. PubMed ID: 20726318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Features of Ras activation by a mislocalized oncogenic tyrosine kinase: FLT3 ITD signals through K-Ras at the plasma membrane of acute myeloid leukemia cells.
    Köthe S; Müller JP; Böhmer SA; Tschongov T; Fricke M; Koch S; Thiede C; Requardt RP; Rubio I; Böhmer FD
    J Cell Sci; 2013 Oct; 126(Pt 20):4746-55. PubMed ID: 23943874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for Differentiation.
    Brendel C; Teichler S; Millahn A; Stiewe T; Krause M; Stabla K; Ross P; Huynh M; Illmer T; Mernberger M; Barckhausen C; Neubauer A
    PLoS One; 2015; 10(4):e0123181. PubMed ID: 25901794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of ras gene mutations in acute myeloid leukemia by the polymerase chain reaction and oligonucleotide probes.
    Chin YM; Bosco JJ; Koh CL
    Singapore Med J; 1992 Feb; 33(1):48-50. PubMed ID: 1598607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Detection of N-RAS Gene Common Mutations in Acute Myeloid Leukemia (AML) Using High Resolution Melting (HRM) Method.
    Zaka Khosravi S; Moonesi M; Moradabadi A; Rajaeinejad M; Heidari MF; Noroozi-Aghideh A
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):125-130. PubMed ID: 35092380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
    Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
    Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 12th codon mutation resulting in c-N-ras activation in acute myelogenous leukemia.
    Needleman SW; Devine SE; Kraus MH
    Leukemia; 1988 Feb; 2(2):91-3. PubMed ID: 3278172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GAP-related domain of neurofibromin attenuates proliferation and downregulates N- and K-Ras activation in Nf1-negative AML cells.
    Morgan KJ; Rowley MA; Wiesner SM; Hasz DE; Van Ness B; Largaespada DA
    Leuk Res; 2007 Aug; 31(8):1107-13. PubMed ID: 17222906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
    Niimi H; Harada H; Harada Y; Ding Y; Imagawa J; Inaba T; Kyo T; Kimura A
    Leukemia; 2006 Apr; 20(4):635-44. PubMed ID: 16467864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-RAS gene activation in acute myeloid leukemia: association with expression of interleukin-6.
    Lübbert M; Oster W; Knopf HP; McCormick F; Mertelsmann R; Herrmann F
    Leukemia; 1993 Dec; 7(12):1948-54. PubMed ID: 8255093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia.
    Shih LY; Huang CF; Wang PN; Wu JH; Lin TL; Dunn P; Kuo MC
    Leukemia; 2004 Mar; 18(3):466-75. PubMed ID: 14737077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.
    Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP
    Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.